Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.075    0.0075 (11.11%)
Bid:
0.07
Ask:
0.08
Spread: 0.01 (14.286%)
Market Cap: £4.29m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Option Purchase and Exercise

13 Mar 2017 10:30

RNS Number : 2649Z
Empyrean Energy PLC
13 March 2017
 

This announcement contains inside information

 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

13 March 2017

Empyrean Energy PLC ('Empyrean' or 'the Company')

 

Option Purchase and Exercise

 

Empyrean confirms that it was notified that on 10 March 2017 that Apnea Holdings Pty Ltd ("Apnea"), a company which is wholly-owned by Tom Kelly, CEO of Empyrean, on that date purchased options (the "Options") in respect of 63,000,000 ordinary shares of 0.2p each in in the Company ("Ordinary Shares") from a third party not connected with the Company (the "Seller"). The terms of the Options are set out below and the total consideration payable by Apnea in respect of the purchase of the Options was AU$275,000 (equivalent to approximately £171,000).

 

Number of Options

Exercise Price

Expiry Date

18,000,000

0.2 pence

19 July 2017

15,000,000

2.1 pence

19 July 2017

15,000,000

4.1 pence

25 March 2018

15,000,000

2.1 pence

26 July 2019

 

Further to the announcement on 15 December 2016, the first tranche of Options detailed above reflects the agreement reached between the Company and the Seller that, if this tranche of Options were to be exercised prior to shareholder approval being granted for the necessary capitalisation from reserves to allow the exercise price to be amended to 0.1p, then this tranche of Options would have an exercise price of 0.2p and convert into a greater number of 18,000,000 Ordinary Shares.

 

Empyrean also announces that, on 10 March 2017, it received notice from Apnea that it intended to exercise its option in relation to 18,000,000 Ordinary Shares at an exercise price of 0.2 pence each. Accordingly, the Company has issued and allotted 18,000,000 Ordinary Shares (the "New Ordinary Shares"). Application will be made for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 17 March 2017. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following this exercise, Tom Kelly has a beneficial interest in 38,881,563 Ordinary Shares, representing 16.21% per cent. of the enlarged issued share capital of the Company.

 

Following the transaction, Empyrean's total issued share capital will comprise 239,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

**ENDS**

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

Tel: +44 (0) 131 220 9771

Beth McKiernan

Tel: +44 (0) 131 220 9778

Nick Tulloch

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Elisabeth Cowell

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

Tel: +44 (0) 20 7236 1177

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tom Kelly

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer of the Company

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Empyrean Energy plc

b)

LEI

-

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 0.2p each ("Ordinary Shares")

Identification code

GB00B09G2351

b)

Nature of the Transaction

Purchase of options in respect of 63,000,000 Ordinary Shares and subsequent exercise of options in respect of 18,000,000 Ordinary Shares at 0.2p per Ordinary Share.

c)

Price(s) and volume(s)

Price

Volume

AU$275,000 (aggregate) (equivalent to approximately £171,000)

Options in respect of 63,000,000 Ordinary Shares with an exercise price of 0.2p to 4.1p per Ordinary Share

 Price

Volume

0.2p

18,000,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

13 March 2017

f)

Place of the transaction

London Stock Exchange, AIM (LON:EME)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMFGFRGNZM
Date   Source Headline
30th Sep 20137:00 amRNSUSD1m Repayment on Macquarie Debt Facility
23rd Sep 20137:00 amRNSRecommences activity in Block A with Conoco, Texas
12th Sep 20138:00 amRNSSugarloaf: Marathon permit update
14th Aug 20132:22 pmRNSHolding(s) in Company
14th Aug 201311:45 amRNSExercise of Options
8th Aug 20138:15 amRNSAppointment of Public Relations Company
8th Aug 20137:45 amRNSSugarloaf: Marathon Update
2nd Aug 20138:30 amRNSSugarloaf: Hedging contract with Macquarie Bank
1st Aug 20138:15 amRNSSugarloaf - Production and Operational Update
26th Jul 20137:00 amRNSPrincipal Office Change
2nd Jul 20133:56 pmRNSResult of AGM and General Meeting
2nd Jul 20131:16 pmRNSAGM Presentation
2nd Jul 20137:00 amRNSFacility repayment
18th Jun 201311:02 amRNSHolding(s) in Company
14th Jun 201310:08 amRNSNotice of General Meeting
11th Jun 201312:35 pmRNSHolding(s) in Company
10th Jun 20138:35 amRNSInvestor presentation
3rd Jun 20131:13 pmRNSNotice of AGM
29th May 20138:30 amRNSOperations Update: Riverbend Project
15th May 20138:00 amRNSFinal Results
1st May 20134:52 pmRNSOperations Update
1st May 20137:30 amRNSOperational Update
30th Apr 20134:26 pmRNSOperational Update
19th Apr 20137:00 amRNSProduction and Operational Update
28th Mar 20137:02 amRNSDrawndown under Macquarie debt facility
25th Mar 20138:00 amRNSEagle Oil Pool Development Project
6th Mar 20138:30 amRNSOperational Update: Sugarloaf Project
26th Feb 20131:51 pmRNSOperational Update
19th Feb 20138:30 amRNSProduction and Operational update
4th Feb 20138:30 amRNSReplacement: Production and Operational update
1st Feb 201310:32 amRNSProduction and Operational Update
7th Jan 201310:53 amRNSConversion of Loan
21st Dec 20127:00 amRNSHalf Yearly Report
14th Dec 20127:33 amRNSIndependent Reserves Report
13th Dec 20128:02 amRNSSugarloaf Production Update
6th Dec 20122:49 pmRNSClarification: Drawdown Convertible Loan Facility
22nd Nov 20127:42 amRNSFurther re Appointment of PR
15th Nov 20127:30 amRNSSugarloaf Production Update
14th Nov 201210:43 amRNSConversion of Loan
31st Oct 20123:44 pmRNSTotal Voting Rights
24th Oct 20129:00 amRNSInvestor Presentation
22nd Oct 20127:00 amRNSAppointment of PR
17th Oct 201211:38 amRNSConversion of Loan
9th Oct 20127:00 amRNSSugarloaf Production Update
21st Sep 20127:00 amRNSSugarloaf Production Update
17th Aug 20129:00 amRNSSugarloaf Production Update
16th Aug 20127:39 amRNSFurther re: US$50m Debt Facility
30th Jul 20128:43 amRNSDirector/PDMR Shareholding
27th Jul 20128:05 amRNSSugarloaf Production Update
26th Jul 20127:56 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.